Breaking: Nasdaq Inc. Reports Major Setback for Grail's Cancer Test
NDAQ faces turbulence as Grail's cancer detection trial falls short. Discover the impact on Nasdaq Inc. and its broader market implications.
Latest news and analysis for Nasdaq Inc. (NDAQ).
NDAQ faces turbulence as Grail's cancer detection trial falls short. Discover the impact on Nasdaq Inc. and its broader market implications.
NDAQ took a keen interest as Arko Corp.'s shares opened below IPO price, indicating market reception. What does this mean for investors?